Clinical Trial Update: A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (YOSEMITE) evaluating Zodasiran in adolescent and adult subjects with Homozygous Familial Hypercholesterolemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Zodasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: RECRUITING